As per the current market research conducted by the CMI Market Research Team, the North America Regenerative Medicine Market size is expected to record a CAGR of 20.5% from 2023 to 2032. In 2022, the market size is projected to reach a valuation of USD 7.80 Billion. By 2032, the valuation is anticipated to reach USD 19.83 Billion.
North America Regenerative Medicine Market: Growth Factors and Dynamics
The increasing prevalence of genetic diseases is a major driver of market expansion. Trauma incidents are increasing rapidly. Expenditure on research and development in the field of regenerative medicine has increased. We have a strong product pipeline for regenerative medicine products. Some of the major factors include:
- Customary conditions are increasing and increasing the frequency of hereditary diseases.
- Increase in trauma incidents.
- Increased investment in research and development of regenerative medicine and strong regenerative medicine product channel.
- Yield and prevalence of stem cell therapy
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 9.1 Billion |
| Projected Market Size in 2032 | USD 19.83 Billion |
| Market Size in 2022 | USD 7.80 Billion |
| CAGR Growth Rate | 20.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Material, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Regenerative Medicine Market: COVID-19 Analysis
The COVID-19 pandemic has had a significant impact on the Regenerative Medicine market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:
The market for regenerative medicine is expanding alongside the advancements in tissue engineering, stem cells, gene therapy, and tissue engineering, all of which are anticipated to fuel the market’s total expansion. The market has expanded as a result of the increasing regulatory approval of drugs used in cutting-edge therapy.
The sector is expanding as a result of numerous programmes and ongoing investments made by both public and private organisations to assist R&D. The scientific research community is served through the NIH Regenerative Medicine Programme, the NIH Stem Cell Project and Library, and the NIH Stem Cell Unit, among other programmes.
The regenerative medicine industry is expanding as a result of efforts made by market participants to finance regenerative medicine research and development. Regenerative medicine uses engineering and biological science ideas to promote the regeneration of diseased or damaged tissues and organs.
A number of regenerative medicine therapies, including those used in chiropractic and wound healing, have recently received FDA approval. Immunological, regenerative medicine is becoming more widely accepted to solve unmet medical needs in the disciplines of cardiology, wound and injury healing, musculoskeletal trauma, oncology, dentistry, ophthalmology, liver disease, and inflammatory and autonomic diseases.
The outcomes of allogeneic cell therapy’s clinical and preclinical research are favourable. COVID-19 has had a favourable effect on the market for regenerative medicine. The current COVID-19 pandemic has offered lucrative potential for market growth because there is an urgent need to find new SARS-COV-2 therapies.
List of the prominent players in the North America Regenerative Medicine Market:
- Integra Life sciences
- Organogenesis Inc.
- Osiris Therapeutics (Smith & Nephew)
- Abbvie Inc. (Allergan Plc.)
- Cook Medical (Cook Biotech Incorporated)
- Others
The North America Regenerative Medicine Market is segmented as follows:
By Product
- Gene Therapies
- Cell Therapies
- Tissue-Engineering
- Small Molecules & Biologics
By Material
- Synthetic material
- Biodegradable synthetic polymers
- Scaffold
- Artificial Vascular Graft
- Materials Hydrogel Material
- Biologically derived material
- Collagen
- Xenogeneic material
- Genetically Engineered Material
- Deoxyribonucleic Acid Transfection Vectors
- Genetically Manipulated Cell
- Three-Dimensional Polymer Technology
- Transgenics
- Fibroblast
- Neural Stem Cell
- Gene-Activated Matrices
- Pharmaceutical
- Biologics
- Small Molecules
By Application
- Wound Care
- Musculoskeletal
- Ophthalmology
- Oncology
- Cardiovascular
- Dermatology
- Neurology
- Others
By End User
- Hospitals & Clinics
- Commercial Industries
- Government & Academic Research Institutes
On the basis of North America Geography
- U.S
- Canada
- Mexico
- Rest of North America